Drug Dictionary


enasidenib (01-17-2018)

Generic Name: enasidenib Trade Name: IDHIFA® For which conditions is this drug approved? IDHIFA is indicated for the treatment of adults with relapsed or refractory acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation as detected... Continue Reading

betrixaban (01-17-2018)

Generic Name: betrixaban Trade Name: BEVYXXA® For which conditions is this drug approved? BEVYXXA is indicated for the prevention of venous thromboembolism (VTE) in adults who are hospitalized for an acute illness and are have risk factors for VTE. VTE... Continue Reading

BEVYXXA® (01-17-2018)

Generic Name: betrixaban Trade Name: BEVYXXA® For which conditions is this drug approved? BEVYXXA is indicated for the prevention of venous thromboembolism (VTE) in adults who are hospitalized for an acute illness and are have risk factors for VTE. VTE... Continue Reading

BESPONSA™ (01-17-2018)

Generic Name: inotuzumab ozogamicin Trade Name: BESPONSA For which conditions is this drug approved? BESPONSA is indicated for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). The labeling contains... Continue Reading

inotuzumab ozogamicin (01-17-2018)

Generic Name: inotuzumab ozogamicin Trade Name: BESPONSA For which conditions is this drug approved? BESPONSA is indicated for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). The labeling contains... Continue Reading

Aliqopa™ (01-17-2018)

Generic Name: copanlisib Trade Name: Aliqopa For which conditions is this drug approved? Aliqopa is indicated for the treatment of adults with relapsed follicular lymphoma who have received at least two prior systemic treatments. Accelerated approval... Continue Reading

copanlisib (01-17-2018)

Generic Name: copanlisib Trade Name: Aliqopa For which conditions is this drug approved? Aliqopa is indicated for the treatment of adults with relapsed follicular lymphoma who have received at least two prior systemic treatments. Accelerated approval... Continue Reading

NERLYNX™ (01-17-2018)

Generic Name: neratinib Trade Name: NERLYNX For which conditions is this drug approved? NERLYNX is indicated for use in adult patients with early-stage. HER2 positive breast cancer following treatment with Herceptin (trastuzumab). What is the mechanism... Continue Reading

neratinib (01-17-2018)

Generic Name: neratinib Trade Name: NERLYNX For which conditions is this drug approved? NERLYNX is indicated for use in adult patients with early-stage. HER2 positive breast cancer following treatment with Herceptin (trastuzumab). What is the mechanism... Continue Reading

Head and Neck Cancer Patients at Risk of Cognitive Problems Following Treatment (01-8-2018)

CancerConnect News: Patients who survive head and neck cancer may be more likely to experience declines in mental function according to the results of a recent study. The findings are drawn from cognitive assessments for 80 survivors of head and neck... Continue Reading

« Previous PageNext Page »